Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

SYBX
Synlogic, Inc. Common Stock
stock NASDAQ

At Close
May 7, 2025
0.00USD-100.000%(-1.12)3,692
0.00Bid   0.00Ask   0.00Spread
Pre-market
May 7, 2025 9:10:30 AM EDT
1.19USD+3.478%(+1.19)100
After-hours
Dec 31, 1969 7:00:00 PM EST
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 6, 2022
07:00AM EST  - On track to initiate Phase 3 for treatment of phenylketonuria (PKU) in H2 2022 -   GlobeNewswire Inc
Dec 13, 2021
05:52AM EST  Synlogic Released Poster 'A Synthetic Live Bacterial Therapeutic Organism for the Treatment of the Human Metabolic Disease Phenylketonuria, Synthetic Biology' for the Engineering, Evolution & Design (SEED) Conference   Benzinga
Nov 24, 2021
10:06AM EST  Benzinga's Top Ratings Upgrades, Downgrades For November 24, 2021   Benzinga
04:57AM EST  Oppenheimer Upgrades Synlogic to Outperform   Benzinga
Nov 23, 2021
08:10AM EST  The Daily Biotech Pulse: Arrowhead Out-Licenses NASH Drug, Tonix Touts COVID-19 Treatment Data, Aadi Jumps On FDA Nod For Rare Tumor Drug   Benzinga
Nov 22, 2021
08:01PM EST  Synlogic :Data Shows Reductions In Plasma Phenylalanine Levels In Patients With Phenylketonuria Treated With SYNB1618   RTTNews
07:45PM EST  Synlogic Presents Data Demonstrating Reductions in Plasma Phenylalanine Levels   PR Newswire
Nov 21, 2021
03:05PM EST  The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week   Benzinga
Nov 11, 2021
11:55AM EST  Synlogic's Return On Capital Employed Insights   Benzinga
05:15AM EST  SVB Leerink Maintains Outperform on Synlogic, Lowers Price Target to $11   Benzinga
Nov 10, 2021
07:45AM EST  Synlogic Q3 EPS $(0.29), Inline, Sales $916.00K Beat $140.00K Estimate   Benzinga
07:11AM EST  Synlogic Q3 Consolidated Net Loss $16.0 Mln Vs. Net Loss $13.2 Mln Last Year   RTTNews
07:01AM EST  Synlogic Reports Third Quarter Financial Results and Provides Business Update   PR Newswire
07:01AM EST  Synlogic Announces Presentation of Phenylketonuria Data at 14th International   PR Newswire
04:09AM EST  Earnings Scheduled For November 10, 2021   Benzinga
Nov 9, 2021
11:31AM EST  Synlogic And Ginkgo Bioworks Announce Nomination Of SYNB1353 Investigational Synthetic Biotic Medicine For Treatment Of Homocystinuria   Benzinga
07:02AM EST  Synlogic and Ginkgo Bioworks Announce Investigational Synthetic Biotic Medicine   PR Newswire
Nov 2, 2021
08:01AM EDT  Synlogic Announces Third Quarter 2021 Conference Call & Participation in   PR Newswire
Oct 28, 2021
07:06AM EDT  Synlogic Announcesd Nature Communications Publication Highlighting Use of Synthetic Biotic Platform to Optimize Therapies for Phenylketonuria   Benzinga
07:01AM EDT  Synlogic Announces Nature Communications Publication Highlighting Use of   PR Newswire
Oct 15, 2021
10:32AM EDT  Synlogic Presents Data On Hyperoxaluria Program At American Society Of Nephrology Kidney Week 2021   Benzinga
10:31AM EDT  Synlogic Presents Data on Hyperoxaluria Program at American Society of   PR Newswire
Oct 13, 2021
06:17AM EDT  HC Wainwright & Co. Maintains Buy on Synlogic, Lowers Price Target to $7   Benzinga
Oct 12, 2021
04:06PM EDT  Synlogic Highlights Publication Of Data Showing Novel Application Of Synthetic biotic Platform In 'Nature'   Benzinga
04:06PM EDT  Synlogic Announces Nature Publication Demonstrating Novel Application of   PR Newswire
Sep 27, 2021
06:32AM EDT  Synlogic Appoints Molly Harper As Chief Business Officer   RTTNews
Sep 23, 2021
07:57AM EDT  The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data   Benzinga
06:09AM EDT  Synlogic Late Wednesday Priced 15M Share Public Offering of Common Stock @$3.00/Share   Benzinga
Sep 22, 2021
11:44PM EDT  Synlogic Prices Public Offering Of 15 Mln Shares At $3/Shr   RTTNews
11:33PM EDT  Synlogic Announces Pricing of Public Offering of Common Stock   PR Newswire
04:02PM EDT  Synlogic Reports Offering Of Common Stock, No Terms Disclosed   Benzinga
04:02PM EDT  Synlogic Announces Proposed Public Offering of Common Stock   PR Newswire
Sep 20, 2021
02:33PM EDT  Mid-Afternoon Market Update: Dow Tumbles 2.5%; BeyondSpring Shares Plunge   Benzinga
12:26PM EDT  Piper Sandler Maintains Overweight on Synlogic, Raises Price Target to $9   Benzinga
12:18PM EDT  Synlogics Shares Rebound From Near-Session Low As Traders Circulate Word Of Raised Price Target From $7 To $9 From Analyst At Piper Sandler; Analyst Maintains Overweight   Benzinga
12:15PM EDT  Synlogics Shares Rebound From Near-Session Low As Traders Circulate Word Of Raised Price Target To $9 From Analyst At Piper Sandler   Benzinga
12:14PM EDT  Synlogics Shares Rebound From Near-Session Low As Traders Circulate Word Of Raised Price Target From Piper Sandler To $9   Benzinga
12:09PM EDT  Mid-Day Market Update: Crude Oil Down 2%; Synlogic Shares Spike Higher   Benzinga
06:53AM EDT  Synlogic Reports Positive Data From Phase 2 Trial   RTTNews
06:33AM EDT  Synlogic Announces Positive Phase 2 Data Evaluating Both SYNB1618 And SYNB1934 For Phenylketonuria   RTTNews
06:31AM EDT  Synlogic Announces Phase 2 Data Demonstrating Reduction In Plasma Phenylalanine Levels In Patients with Phenylketonuria   Benzinga
06:30AM EDT  Synlogic Announces Positive Phase 2 Data Demonstrating Reduction in Plasma   PR Newswire
Sep 10, 2021
07:35PM EDT  Synlogic Presents Data On SYNB8802 For Enteric Hyperoxaluria At American Urological Association (AUA) Annual Meeting   Benzinga
10:32AM EDT  Synlogic Presents Data On SYNB8802 For Enteric Hyperoxaluria At American Urological Association Annual Meeting   RTTNews
10:29AM EDT  Synlogic Presents Data on SYNB8802 for Enteric Hyperoxaluria at American   PR Newswire
10:28AM EDT  Synlogic Presents at Global PKU Patient Meeting   PR Newswire
Aug 12, 2021
08:09AM EDT  The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma   Benzinga
06:40AM EDT  Synlogic Q2 EPS $(0.28) Beats $(0.31) Estimate, Sales $246.00K Down From $445.00K YoY   Benzinga
06:34AM EDT  Synlogic Q2 Net $14.5 Mln Vs. Net Loss $15.5 Mln Last Year   RTTNews
06:31AM EDT  Synlogic Reports Second Quarter Financial Results and Provides Business Update   PR Newswire
04:14AM EDT  Earnings Scheduled For August 12, 2021   Benzinga
Aug 9, 2021
11:07AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
Aug 5, 2021
09:03AM EDT  Synlogic Announces Second Quarter 2021 Conference Call & Participation in   PR Newswire
Jul 30, 2021
01:42PM EDT  Synlogic-Sponsored Study Titled 'Safety and Tolerability of SYNB1934 in Healthy Adult Volunteers' Posted To ClinicalTrials.Gov   Benzinga
Jul 22, 2021
12:04PM EDT  Synlogic Publishes Papers in Nature Journals Demonstrating Proof-of-Mechanism and Potential of Synthetic Biotic Platform for the Treatment of Phenylketonuria (PKU)   Benzinga
12:01PM EDT  and Potential of Synthetic Biotic Platform for the Treatment of Phenylketonuria (PKU)   PR Newswire
Jul 15, 2021
06:36AM EDT  Synlogic Begins Phase 1 Study Of SYNB1934 For Phenylketonuria   RTTNews
06:33AM EDT  Synlogic Announces Initiation Of Phase 1 Study of SYNB1934, A Next-Generation Strain For The Treatment of Phenylketonuria   Benzinga
06:31AM EDT  Synlogic Announces Initiation of Phase 1 Study of SYNB1934, a Next-Generation   PR Newswire
Jun 28, 2021
06:09AM EDT  HC Wainwright & Co. Maintains Buy on Synlogic, Lowers Price Target to $9   Benzinga
Jun 17, 2021
10:26AM EDT  Synlogic, Roche Ink Research Pact For Inflammatory Bowel Disease Therapy   Benzinga
08:02AM EDT  Synthetic biology firm Synlogic, Inc. (SYBX) announced Thursday that it has entered into a research collaboration agreement with Swiss drug major Roche Group (RHHBY) for the discovery of a novel Synthetic Biotic medicine for the treatment of inflammatory bowel disease (IBD).   RTTNews
07:40AM EDT  Synlogic Enters Research Collaboration Agreement With Roche   RTTNews
07:34AM EDT  Synlogic Enters Research Collaboration with Roche for Development of Novel Therapy to Treat Inflammatory Bowel Disease   Benzinga
07:31AM EDT  Synlogic Enters Research Collaboration with Roche for Development of Novel   PR Newswire
Jun 15, 2021
10:41AM EDT  Synlogic Says Presents Additional Preclincal Data On Therapeutic Candidates SYNB1934 For Phenylketonuria And SYNB8802 For Enteric Hyperoxaluria At Synthetic Biology: Engineering, Evolution & Design Conference   Benzinga
10:39AM EDT  SYNB1934 for Phenylketonuria (PKU) and SYNB8802 for Enteric Hyperoxaluria at Synthetic Biology: Engineering, Evolution & Design (SEED) Conference   PR Newswire
09:21AM EDT  Synlogic Shares Quiet; Traders Circulate Co's Poster Presentations Titled 'Development of a Synthetic Biotic' And 'Synthetic Biology Approaches for the Optimization and Improvement of a Live Bacterial Therapeutic'   Benzinga
Jun 3, 2021
08:31AM EDT  Synlogic Reminds Stockholders of 2021 Annual General Meeting Details   PR Newswire
May 25, 2021
08:31AM EDT  Synlogic to Present at Upcoming Virtual Banking and Industry Conference   PR Newswire
May 24, 2021
10:36AM EDT  Synlogic Sunday Afternoon Highlighted Presentation Of Data On Novel Approach For Treatment Of Inflammatory Bowel Disease At Digestive Week   Benzinga
May 23, 2021
01:59PM EDT  Synlogic Presents Data at Digestive Disease Week (DDW) on a Novel Approach for   PR Newswire
May 13, 2021
08:10AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use   Benzinga
06:41AM EDT  Synlogic Q1 Consolidated Net Loss $15.0 Mln Or $0.36/Shr Vs Loss $15.8 Mln Or $0.46/Shr Last Year   RTTNews
06:31AM EDT  Synlogic Q1 EPS $(0.36) Beats $(0.39) Estimate   Benzinga
06:30AM EDT  Synlogic Reports First Quarter Financial Results and Provides Business Update   PR Newswire
04:15AM EDT  Earnings Scheduled For May 13, 2021   Benzinga
May 6, 2021
08:02AM EDT  Synlogic Announces First Quarter 2021 Conference Call & Webcast   PR Newswire
Apr 16, 2021
08:01AM EDT  The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs   Benzinga
06:08AM EDT  Synlogic Prices 10M Share Common Stock Offering At $3/Share   Benzinga
06:02AM EDT  Synlogic Prices Public Offering Of 10 Mln Shares At $3/Shr   RTTNews
06:01AM EDT  Synlogic Announces Pricing of Public Offering of Common Stock   PR Newswire
Apr 15, 2021
04:03PM EDT  Synlogic Announces Proposed Public Offering Of Common Stock; Size Not Disclosed   Benzinga
04:02PM EDT  Synlogic Announces Proposed Public Offering of Common Stock   PR Newswire
Apr 13, 2021
09:24AM EDT  Synlogic Presents Data Demonstrating Activity Of Solid Oral Formulation Of SYNB1618   RTTNews
09:24AM EDT  Synlogic Highlights Presentation Of Data Showing Activity Of Solid Oral Formulation Of SYNB1618 At American College Of Medical Genetics Meeting   Benzinga
09:21AM EDT  Synlogic Presents Data Demonstrating Activity of a Solid Oral Formulation of   PR Newswire
Apr 10, 2021
09:38AM EDT  Synlogic Presents Data from SYNB1891 Phase 1 Trial at American Association for   PR Newswire
Apr 1, 2021
03:34PM EDT  Synlogic to Present at Upcoming Virtual Banking and Industry Conferences   PR Newswire
Mar 25, 2021
07:58AM EDT  The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut   Benzinga
06:41AM EDT  Synlogic Q4 Net Loss $14.6 Mln Or $0.39/Shr Vs Loss Of $12.8 Mln Or $0.37/Shr Last Year   RTTNews
06:32AM EDT  Synlogic Q4 EPS $(0.39) Beats $(0.40) Estimate   Benzinga
06:30AM EDT  Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and   PR Newswire
04:03AM EDT  Earnings Scheduled For March 25, 2021   Benzinga
Mar 24, 2021
04:10PM EDT  Synlogic Announces SYNB8802 Has Achieved Proof Of Mechanism In A Dietary Hyperoxaluria Study   Benzinga
04:05PM EDT  Synlogic Announces SYNB8802 Will Advance to Phase 1B Proof of Concept Study   PR Newswire
Mar 18, 2021
10:02AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For March 18, 2021   Benzinga
09:15AM EDT  JonesTrading Initiates Coverage On Synlogic with Buy Rating, Announces Price Target of $15   Benzinga
Mar 16, 2021
02:45PM EDT  Synlogic Announces Fourth Quarter and Full Year 2020 Conference Call & Webcast   PR Newswire
Mar 8, 2021
07:19AM EST  Synlogic Promotes Caroline Kurtz To Chief Development Officer   RTTNews
07:01AM EST  Synlogic Announces Promotion of Dr. Caroline Kurtz to Chief Development Officer   PR Newswire
Mar 2, 2021
08:41AM EST  Synlogic Granted US Patent Titled 'Bacteria engineered to treat a disease or disorder'   Benzinga
Feb 15, 2021
07:00AM EST  Synlogic to Present at Upcoming Virtual Banking and Industry Conferences   PR Newswire
Feb 10, 2021
07:34AM EST  The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs   Benzinga
07:01AM EST  Synlogic Appoints Lisa Kelly-Croswell to its Board of Directors   PR Newswire
Feb 9, 2021
08:10AM EST  The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement   Benzinga
Feb 5, 2021
07:44AM EST  The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street   Benzinga
Feb 2, 2021
06:31AM EST  Joint Team from MIT and Synlogic Named a Biotechnology Grand Challenge Winner   PR Newswire
Jan 22, 2021
07:22AM EST  The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa   Benzinga
Jan 13, 2021
10:21AM EST  Mid-Morning Market Update: Markets Slightly Higher; IHS Markit Profit Beats Views   Benzinga
08:38AM EST  Chardan Capital Maintains Buy on Synlogic, Raises Price Target to $10   Benzinga
Jan 11, 2021
06:41AM EST  Synlogic Announces 2020 Corporate Milestones   Benzinga
06:30AM EST  Synlogic Outlines Upcoming Clinical Milestones   PR Newswire
Dec 14, 2020
06:35AM EST  Synlogic Advances its Cancer Treatment into the Combination Therapy Stage of its Phase 1 Trial   Benzinga
06:06AM EST  Synlogic Says SYNB1891 Advanced Into Combination Therapy Stage Of The Phase 1 Trial   RTTNews
06:01AM EST  Checkpoint Inhibitor in the on-going Phase 1 Study for the Treatment of Solid Tumors and Lymphoma   PR Newswire
Dec 9, 2020
06:31AM EST  Synlogic Appoints Michael Heffernan To Board   RTTNews
06:30AM EST  Synlogic Appoints Michael Heffernan to its Board of Directors   PR Newswire
Dec 7, 2020
12:29PM EST  Synlogic Presents SYNB8802 For Enteric Hyperoxaluria At The American Institute Of Chemical Engineers Conference On Microbiome Engineering   Benzinga
12:28PM EST  Synlogic Presents SYNB8802 for Enteric Hyperoxaluria at the American Institute   PR Newswire
Nov 25, 2020
02:57PM EST  'The U.S. government has agreed to loan Synlogic partner Ginko Bioworks $1.1B for COVID-19 testing and the production of raw materials for therapies that may help address future pandemics' - Zack Morris   Benzinga
Nov 18, 2020
06:31AM EST  Synlogic to Present at Upcoming Virtual Banking Conference   PR Newswire
Nov 5, 2020
08:42AM EST  Recap: Synlogic Q3 Earnings   Benzinga
07:54AM EST  The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping   Benzinga
06:50AM EST  Synlogic Q3 EPS $(0.36) Beats $(0.47) Estimate   Benzinga
06:41AM EST  Synlogic Q3 Consolidated Net Loss $13.2 Mln Or $0.36/shr Vs. Net Loss $13.3 Mln Or $0.39/shr Last Year   RTTNews
06:31AM EST  Synlogic Reports Third Quarter 2020 Financial Results and Provides Business   PR Newswire
04:34AM EST  Earnings Scheduled For November 5, 2020   Benzinga
Nov 4, 2020
04:28PM EST  Synlogic Announces That It Has Initiates Its Phase 1 Study Of The SYNB8802 For The Treatment Of Enteric Hyperoxaluria   Benzinga
04:06PM EST  Synlogic Initiates Phase 1 Study of SYNB8802 for the Treatment of Enteric   PR Newswire
Nov 1, 2020
09:40AM EST  The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings   Benzinga
Oct 27, 2020
06:31AM EDT  Synlogic Announces Third Quarter 2020 Conference Call & Webcast   PR Newswire
Oct 22, 2020
06:31AM EDT  Synlogic Presents Preclinical Data on SYNB8802 for Enteric Hyperoxaluria at   PR Newswire
Sep 14, 2020
07:07AM EDT  Synlogic Appoints David Hava As Chief Scientific Officer   RTTNews
07:02AM EDT  Synlogic Appoints David Hava, Ph.D., as Chief Scientific Officer   Benzinga
Sep 8, 2020
11:47AM EDT  Synlogic to Present at Upcoming Virtual Banking Conferences   PR Newswire
Aug 6, 2020
10:34AM EDT  Synlogic Earlier Reported Q2 EPS $(0.44) Beats $(0.46) Estimate, Sales $445.00K Beat $250.00K Estimate   Benzinga
07:57AM EDT  The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO   Benzinga
07:01AM EDT  Synlogic Reports Second Quarter 2020 Financial Results and Provides Business   PR Newswire
Jul 31, 2020
02:50PM EDT  Synlogic to Present at Upcoming Virtual Banking Conferences   PR Newswire
Jul 30, 2020
08:27AM EDT  Synlogic Promotes Tony Awad To COO Role   Benzinga
07:01AM EDT  Synlogic Announces Promotion of Antoine 'Tony' Awad to Chief Operating Officer   PR Newswire
Jul 28, 2020
07:30AM EDT  Synlogic Announces Second Quarter 2020 Conference Call & Webcast   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC